LU75011A1 - - Google Patents

Info

Publication number
LU75011A1
LU75011A1 LU75011A LU75011A LU75011A1 LU 75011 A1 LU75011 A1 LU 75011A1 LU 75011 A LU75011 A LU 75011A LU 75011 A LU75011 A LU 75011A LU 75011 A1 LU75011 A1 LU 75011A1
Authority
LU
Luxembourg
Application number
LU75011A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19752523676 external-priority patent/DE2523676A1/de
Priority claimed from DE19762616304 external-priority patent/DE2616304A1/de
Application filed filed Critical
Publication of LU75011A1 publication Critical patent/LU75011A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU75011A 1975-05-26 1976-05-24 LU75011A1 (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19752523676 DE2523676A1 (de) 1975-05-26 1975-05-26 Neue prostanderivate und verfahren zu ihrer herstellung
DE19762616304 DE2616304A1 (de) 1976-04-12 1976-04-12 Neue prostansaeurederivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
LU75011A1 true LU75011A1 (it) 1977-01-20

Family

ID=25768952

Family Applications (1)

Application Number Title Priority Date Filing Date
LU75011A LU75011A1 (it) 1975-05-26 1976-05-24

Country Status (14)

Country Link
US (2) US4105792A (it)
JP (1) JPS51143643A (it)
AT (1) AT359657B (it)
AU (1) AU510695B2 (it)
CA (1) CA1091226A (it)
CH (1) CH623036A5 (it)
DK (1) DK229476A (it)
FR (1) FR2312240A1 (it)
GB (1) GB1553710A (it)
HU (1) HU177906B (it)
IE (1) IE44255B1 (it)
LU (1) LU75011A1 (it)
NL (1) NL7605381A (it)
SE (1) SE7605925L (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058564A (en) * 1976-07-26 1977-11-15 The Upjohn Company Aliphatic 2-decarboxy-2-hydroxymethyl-13,14-didehydro-PG compounds
US4149006A (en) * 1977-01-24 1979-04-10 G. D. Searle & Co. Prostaglandin derivatives having alkynyl, hydroxy and aryloxy junctions in the 2β side chain
US4171331A (en) * 1978-06-05 1979-10-16 Miles Laboratories, Inc. 1 And 2-substituted analogues of certain prostaglandins
DE3405181A1 (de) * 1984-02-10 1985-08-22 Schering AG, 1000 Berlin und 4709 Bergkamen Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US5238961A (en) * 1990-06-14 1993-08-24 Allergan, Inc. Pgf 1-alcohols and their use as ocular hypotensives
US5139491A (en) * 1990-12-06 1992-08-18 Allergan, Inc. 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives
US5767154A (en) * 1991-02-07 1998-06-16 Allergan 5-trans-prostaglandins of the F series and their use as ocular hypotensives
IE920397A1 (en) * 1991-02-07 1992-08-12 Allergan Inc 2-decarboxyl-2-hydroxyalkyl-5-trans prostaglandin f¹derivatives
US5312832A (en) * 1991-05-17 1994-05-17 Allergan, Inc. Ocular hypotensive 2-decarboxyl-2-acylthioalkyl prostaglandin derivatives
US5972991A (en) 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5834498A (en) * 1992-09-21 1998-11-10 Allergan Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5385945A (en) * 1992-10-21 1995-01-31 Allergan, Inc. 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US6184250B1 (en) 1993-08-03 2001-02-06 Alcon Laboratories, Inc. Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
US5721273A (en) 1993-12-15 1998-02-24 Alcon Laboratories, Inc. Use of certain 9-halo-13,14-dihydroprostaglandins to treat glaucoma and ocular hypertension
US5545665A (en) 1993-12-28 1996-08-13 Allergan Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
US7851504B2 (en) 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
WO2010102078A1 (en) 2009-03-04 2010-09-10 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3069322A (en) * 1958-05-28 1962-12-18 Bergstrom Sune Pge and pgf
US3723528A (en) * 1967-10-09 1973-03-27 Upjohn Co Prostaglandin oximes and oxime ethers
US3922293A (en) * 1971-12-30 1975-11-25 Upjohn Co Prostaglandin F-type 9-monoacylates
GB1451798A (en) * 1973-08-02 1976-10-06 Ici Ltd Prostanoic acid derivatives
GB1468830A (en) * 1974-01-26 1977-03-30 May & Baker Ltd Cyclopentane derivatives
US3970685A (en) * 1974-06-05 1976-07-20 Syntex (U.S.A.) Inc. (DL)-13-Substituted sulfinyl-prostaglandin-like compounds
US4117119A (en) * 1975-03-11 1978-09-26 Ono Pharmaceutical Company 15-cyclobutyl-prostaglandins

Also Published As

Publication number Publication date
SE7605925L (sv) 1976-11-27
GB1553710A (en) 1979-09-26
AT359657B (de) 1980-11-25
AU1422576A (en) 1977-12-01
HU177906B (en) 1982-01-28
ATA373376A (de) 1980-04-15
IE44255L (en) 1976-11-26
AU510695B2 (en) 1980-07-10
FR2312240B1 (it) 1979-09-21
NL7605381A (nl) 1976-11-30
IE44255B1 (en) 1981-09-23
US4256745A (en) 1981-03-17
FR2312240A1 (fr) 1976-12-24
CA1091226A (en) 1980-12-09
JPS51143643A (en) 1976-12-10
CH623036A5 (it) 1981-05-15
US4105792A (en) 1978-08-08
DK229476A (da) 1976-11-27

Similar Documents

Publication Publication Date Title
CH599589B5 (it)
CH596282A5 (it)
BE826796A (it)
BE846112A (it)
LU75011A1 (it)
BG22434A1 (it)
BG22558A1 (it)
BG22639A1 (it)
BG22644A1 (it)
BG22902A1 (it)
BG23519A1 (it)
BG26465A1 (it)
CH579442A5 (it)
CH583647A5 (it)
CH586541A5 (it)
CH586768A5 (it)
CH588211A5 (it)
CH588663A5 (it)
CH588681A5 (it)
CH589383A5 (it)
CH589455A5 (it)
CH590391A5 (it)
CH590459A5 (it)
CH591438A5 (it)
CH591866A5 (it)